Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 46: | Line 46: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Actinic keratoses''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Actinic keratoses''' | ||
| style="background: #F5F5F5; padding: 5px;" |pain | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |hyperkeratosis | |||
| style="background: #F5F5F5; padding: 5px;" |erythema | |||
| style="background: #F5F5F5; padding: 5px;" |less pigmentation, and tend to be somewhat smaller in size. | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 55: | Line 59: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Skin biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 112: | Line 112: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Two-thirds arise in normal skin, the rest in existing moles | |||
* Genetic component in some cases with a positive family history | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Paget disease''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Paget disease''' | ||
Line 134: | Line 136: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Color usually pink, purple or normal skin color | |||
| style="background: #F5F5F5; padding: 5px;" |Usually have an asymmetrical shape with an irregular border | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 142: | Line 146: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |skin biopsy | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Do not make melanin, so lesions are not pigmented | |||
* | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Superficial basal cell carcinoma ''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Superficial basal cell carcinoma ''' | ||
Line 170: | Line 174: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |waxy, "stuck on," often hyperkeratotic appearance | |||
| style="background: #F5F5F5; padding: 5px;" |On dermatoscopic evaluation, presence of horned cysts and hairpin-shaped blood vessels | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 178: | Line 184: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Skin biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 204: | Line 208: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |multiple, red- to brown-colored, small papules that | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 215: | Line 220: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* primarily arise on genitals | |||
* induced by human papillomavirus (HPV) infection | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nummular eczema''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nummular eczema''' |
Revision as of 15:34, 30 January 2019
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histopathology | |||||||||||||
Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | ||||
Cutaneous squamous cell carcinoma | pain | erythema | indurated | hyperkeratotic | increased size | skin biopsy |
| ||||||||
Actinic keratoses | pain | hyperkeratosis | erythema | less pigmentation, and tend to be somewhat smaller in size. | Skin biopsy | ||||||||||
Merkel cell carcinoma | |||||||||||||||
Prurigo nodules | |||||||||||||||
Nodular malignant melanoma |
| ||||||||||||||
Paget disease | |||||||||||||||
Amelanotic melanoma | Color usually pink, purple or normal skin color | Usually have an asymmetrical shape with an irregular border | skin biopsy |
| |||||||||||
Superficial basal cell carcinoma |
|
skin biopsy | |||||||||||||
Inflamed seborrheic keratosis | waxy, "stuck on," often hyperkeratotic appearance | On dermatoscopic evaluation, presence of horned cysts and hairpin-shaped blood vessels | Skin biopsy | ||||||||||||
Viral warts | |||||||||||||||
Bowenoid papulosis | multiple, red- to brown-colored, small papules that |
| |||||||||||||
Nummular eczema | |||||||||||||||
Psoriasis | |||||||||||||||
Basal cell carcinoma | |||||||||||||||
Atypical fibroxanthoma | |||||||||||||||
Amelanotic melanoma | |||||||||||||||
Cutaneous metastases of internal malignancy | |||||||||||||||
Pyoderma gangrenosum | |||||||||||||||
Venous stasis ulcers | |||||||||||||||
Sebaceous Hyperplasia | |||||||||||||||
Traumatic ulcers | |||||||||||||||
Bowen Disease | |||||||||||||||
Sebaceous Hyperplasia | |||||||||||||||
Trichoepithelioma | |||||||||||||||
Allergic Contact Dermatitis | |||||||||||||||
Atopic Dermatitis | |||||||||||||||
Atypical Fibroxanthoma | |||||||||||||||
Benign Skin Lesions | |||||||||||||||
Chemical Burns | |||||||||||||||
Limbal Dermoid | |||||||||||||||
Sebaceous cell carcinoma | |||||||||||||||
rhabdomyosarcoma | |||||||||||||||
Benign hereditary intraepithelial dyskeratosis | |||||||||||||||
Nevus | |||||||||||||||
primary acquired melanosis | |||||||||||||||
HPV | |||||||||||||||
fibrous xanthoma | |||||||||||||||
Juvenile xanthogranuloma |